Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal Lesions
NCT ID: NCT05674123
Last Updated: 2023-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2020-01-15
2022-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RObotic Versus LAparoscopic Resection for Rectal Cancer
NCT01736072
Eval. of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Total Mesorectal Excision Surgery
NCT02423174
A Trial to Assess Robot-assisted Surgery and Laparoscopy-assisted Surgery in Patients With Mid or Low Rectal Cancer
NCT01423214
Robotic Assisted Transanal Total Mesorectal Excision Surgery for Rectal Cancer in Low Site
NCT03422835
Initial Safety of SFM Plus OTOLoc for Creating Side-to-side or End-to-side Colorectal Anastomoses
NCT07276529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To assess the rates of complete en bloc resection and adverse events of the Flex Robotic System for distal colorectal lesions.
OUTLINE:
Patients undergo resection with Flex Robotic System on study. Patients also undergo colonoscopy with or without rectal endoscopic ultrasound at screening.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Device Feasibility (Flex Robotic System)
Patients undergo resection with Flex Robotic System on study. Patients also undergo colonoscopy with or without rectal endoscopic ultrasound at screening.
Colonoscopy
Undergo colonoscopy
Endoscopic Ultrasound
Undergo rectal endoscopic ultrasound
Medical Chart Review
Ancillary studies
Medical Device Usage and Evaluation
Undergo resection with the Flex Robotic System
Resection
Undergo resection with the Flex Robotic System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colonoscopy
Undergo colonoscopy
Endoscopic Ultrasound
Undergo rectal endoscopic ultrasound
Medical Chart Review
Ancillary studies
Medical Device Usage and Evaluation
Undergo resection with the Flex Robotic System
Resection
Undergo resection with the Flex Robotic System
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Polypoid (0-Is) and non-polypoid (0-IIa, 0-IIb and 0-IIc) lateral spreading lesions according to Paris classification
* Colorectal lesions situated between 5 and 15 cm from the dentate line
* Colorectal mucosal lesions ranging from 1.5 to 7 cm in maximum diameter
* Colorectal subepithelial lesions \< 2 cm in size
* Absence of uncorrectable bleeding disorder or coagulopathy
* Platelet count \> 50,000
* International normalized ratio (INR) \< 1.5
* Ability to give informed consent
Exclusion Criteria
* Presence of medical conditions for which a transanal approach is contraindicated (e.g., anal stricture, radiation proctopathy)
* Excavated (0-III) colorectal lesions according to Paris classification
* Suboptimal colon preparation
* Clinical discretion of the provider
22 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Louis M Wong Kee Song
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2022-09474
Identifier Type: REGISTRY
Identifier Source: secondary_id
19-009663
Identifier Type: OTHER
Identifier Source: secondary_id
19-009663
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.